BIO Bio-Rad Laboratories Inc

USD 368.92 +0.50 ( +0.14)%
Icon

Bio-Rad Laboratories Inc (BIO) Stock Analysis and Price Targets

COMMON STOCK | Medical Devices | NYE
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Hold

Average User
Rating

USD 368.92

+0.50 (+0.14)%

USD 10.14B

0.20M

USD 371.33(+0.65%)

USD 500.00 (+35.53%)

Icon

BIO

Bio-Rad Laboratories Inc (USD)
COMMON STOCK | NYE
USD 368.92
+0.50 ( +0.14)%
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Hold

Average User
Rating

USD 10.14B

USD 500.00 (+35.53%)

USD 368.92

Bio-Rad Laboratories Inc (BIO) Stock Forecast

Show ratings and price targets of :
USD 371.33
(+0.65%)

Based on the Bio-Rad Laboratories Inc stock forecast from 5 analysts, the average analyst target price for Bio-Rad Laboratories Inc is USD 371.33 over the next 12 months. Bio-Rad Laboratories Inc’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Bio-Rad Laboratories Inc is Slightly Bearish, which is based on 4 positive signals and 7 negative signals. At the last closing, Bio-Rad Laboratories Inc’s stock price was USD 368.92. Bio-Rad Laboratories Inc’s stock price has changed by +12.27% over the past week, +7.34% over the past month and -35.92% over the last year.

No recent analyst target price found for Bio-Rad Laboratories Inc
No recent average analyst rating found for Bio-Rad Laboratories Inc

Company Overview Bio-Rad Laboratories Inc

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufacture...Read More

N/A

N/A

7,700

N/A

USD

USA

Adjusted Closing Price for Bio-Rad Laboratories Inc (BIO)

Loading...

Unadjusted Closing Price for Bio-Rad Laboratories Inc (BIO)

Loading...

Share Trading Volume for Bio-Rad Laboratories Inc Shares

Loading...

Compare Performance of Bio-Rad Laboratories Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BIO

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Bio-Rad Laboratories Inc (Sector: Medical Devices )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ABT
Abbott Laboratories -0.95 (-0.80%) USD205.71B 36.09 19.96

Frequently Asked Questions About Bio-Rad Laboratories Inc (BIO) Stock

Based on ratings from 5 analysts Bio-Rad Laboratories Inc's stock is Buy . Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 5 buy, sell and 4 hold ratings.

Unfortunately we do not have enough data on BIO's stock to indicate if its a good dividend stock.

Based on targets from 5 analysts, the average taret price for BIO is USD 371.33 over the next 12 months. The maximum analyst target price is USD 450 while the minimum anlayst target price is USD 300.

Unfortunately we do not have enough data on BIO's stock to indicate if its overvalued.

The last closing price of BIO's stock was USD 368.92.

The most recent market capitalization for BIO is USD 10.14B.

Based on targets from 5 analysts, the average taret price for BIO is projected at USD 371.33 over the next 12 months. This means that BIO's stock price may go up by +0.65% over the next 12 months.

We can't find any ETFs which contains Bio-Rad Laboratories Inc's stock.

As per our most recent records Bio-Rad Laboratories Inc has 7,700 Employees.

Sorry we do not have any infomation available on Bio-Rad Laboratories Inc's address.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Frequently Asked Questions About Bio-Rad Laboratories Inc (BIO) Stock

Based on ratings from 5 analysts Bio-Rad Laboratories Inc's stock is Buy . Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 5 buy, sell and 4 hold ratings.

Unfortunately we do not have enough data on BIO's stock to indicate if its a good dividend stock.

Based on targets from 5 analysts, the average taret price for BIO is USD 371.33 over the next 12 months. The maximum analyst target price is USD 450 while the minimum anlayst target price is USD 300.

Unfortunately we do not have enough data on BIO's stock to indicate if its overvalued.

The last closing price of BIO's stock was USD 368.92.

The most recent market capitalization for BIO is USD 10.14B.

Based on targets from 5 analysts, the average taret price for BIO is projected at USD 371.33 over the next 12 months. This means that BIO's stock price may go up by +0.65% over the next 12 months.

We can't find any ETFs which contains Bio-Rad Laboratories Inc's stock.

As per our most recent records Bio-Rad Laboratories Inc has 7,700 Employees.

Sorry we do not have any infomation available on Bio-Rad Laboratories Inc's address.
Loading...